Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3298101
Max Phase: Preclinical
Molecular Formula: C19H12FI2NO3
Molecular Weight: 575.12
Molecule Type: Small molecule
Associated Items:
ID: ALA3298101
Max Phase: Preclinical
Molecular Formula: C19H12FI2NO3
Molecular Weight: 575.12
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)c1cc(I)cc(I)c1O
Standard InChI: InChI=1S/C19H12FI2NO3/c20-11-1-5-14(6-2-11)26-15-7-3-13(4-8-15)23-19(25)16-9-12(21)10-17(22)18(16)24/h1-10,24H,(H,23,25)
Standard InChI Key: AQMUNMRLSASTHW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 575.12 | Molecular Weight (Monoisotopic): 574.8891 | AlogP: 5.79 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.56 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.41 | CX Basic pKa: | CX LogP: 6.26 | CX LogD: 5.27 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.39 | Np Likeness Score: -1.27 |
1. Gooyit M, Tricoche N, Lustigman S, Janda KD.. (2014) Dual protonophore-chitinase inhibitors dramatically affect O. volvulus molting., 57 (13): [PMID:24918716] [10.1021/jm5006435] |
Source(1):